Trials / Completed
CompletedNCT03619330
Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.
Effects of Liraglutide and Testosterone Replacement Therapy on Features of Hypogonadism and Weight Loss in Obese Men With Persistent Features of Hypogonadism.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University Medical Centre Ljubljana · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to compare the effects of liraglutide and testosterone replacement therapy on features of hypogonadism and weight loss in obese men with persistent features of hypogonadism after unsuccessful lifestyle measures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | liraglutide | In the liraglutide group liraglutide was initiated at a dose of 1.2 mg injected sc once per day and increased to 3 mg/day after 1 week. |
| DRUG | Testosterone | In the testosterone group Androtop gel 5 grams (50 mg of testosterone) was applied once a day on a dry skin. |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2018-08-07
- Last updated
- 2018-08-07
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT03619330. Inclusion in this directory is not an endorsement.